Back to results
US 2001/0036955 A1Published application
Method of inhibiting angiogenesis
AssigneeGenentech, Inc.
InventorsMary E. Gerritsen, Xiaohua E. Xin
Life of this patent
Estimating the term…
Abstract
Angiogenesis is inhibited and the growth of tumors is treated by administering an effective amount of a PPAR gamma ligand/agonist, optionally with an RXR receptor ligand.
Claims29
A method of inhibiting angiogenesis comprising:
- (a) identifying a patient in need of an angiogenesis inhibitor;
- and
- (b) administering to the patient a therapeutically effective amount of a PPAR gamma ligand, wherein angiogenesis is inhibited in the patient.
A method of inhibiting angiogenesis in a patient, comprising:
- (a) identifying a patient with a disease or disorder selected from the group consisting of a neoplasm, rheumatoid arthritis, psoriasis, atherosclerosis, thyroid hyperplasia, endometriosis, lung inflammation, obesity, and chronic inflammation;
- and
- (b) administering an angiogenesis inhibiting amount of a PPAR gamma ligand, wherein angiogenesis is inhibited in the patient.
A method of providing an article of manufacture for inhibiting angiogenesis in a patient, comprising the step of providing:
- (a) a container comprising a composition having a therapeutically effective amount of a PPAR gamma ligand therein;
- and
- (b) an indication that the composition can be used to inhibit angiogenesis.
An article of manufacture for inhibiting angiogenesis comprising:
- (a) a container;
- (b) a composition within the container comprising a therapeutically effective amount of a PPAR gamma ligand;
- and
- (c) an indication that the composition can be used to inhibit angiogenesis.
1 more element
Dependencies are inferred from the claim text.